| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |